BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Li WX, Chen Y, Li XF, Li HD, Huang HM, Bu FT, Pan XY, Yang Y, Huang C, Meng XM, Li J. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis. Cell Death Dis 2018;9:1021. [PMID: 30282980 DOI: 10.1038/s41419-018-1032-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 You H, Wang L, Bu F, Meng H, Pan X, Li J, Zhang Y, Wang A, Yin N, Huang C, Li J. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. FASEB J 2021;35:e21700. [PMID: 34105828 DOI: 10.1096/fj.202002319RRR] [Reference Citation Analysis]
2 Peng XF, Huang SF, Chen LJ, Xu L, Ye WC. Targeting epigenetics and lncRNAs in liver disease: From mechanisms to therapeutics. Pharmacol Res 2021;172:105846. [PMID: 34438063 DOI: 10.1016/j.phrs.2021.105846] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Meng H, Niu R, Huang C, Li J. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC. Cells 2022;11:1948. [PMID: 35741077 DOI: 10.3390/cells11121948] [Reference Citation Analysis]
4 Chen X, Zhu S, Chen SY, Wang JN, Sun LJ, Tao SM, Li XF, Li HD, Sun YY, Xu CH, Suo XG, Ji ML, Huang C, Meng XM, Li J. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. Int Immunopharmacol 2022;110:109034. [PMID: 35834952 DOI: 10.1016/j.intimp.2022.109034] [Reference Citation Analysis]
5 Li H, Chen X, Xu J, Du X, Yang Y, Li J, Yang X, Huang H, Li X, Wu M, Zhang C, Zhang C, Li Z, Wang H, Meng X, Huang C, Li J. DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathway. Clinical Science 2020;134:1935-56. [DOI: 10.1042/cs20200031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ma X, Tang M, Lu L, Zheng J, Huang J, Li J, Luo W. Effects of salvianolic acid B on liver fibrosis: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e21036. [PMID: 32664111 DOI: 10.1097/MD.0000000000021036] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Pan XY, You HM, Wang L, Bi YH, Yang Y, Meng HW, Meng XM, Ma TT, Huang C, Li J. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling. Theranostics 2019;9:4308-23. [PMID: 31285763 DOI: 10.7150/thno.32710] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
8 Yang YR, Bu FT, Yang Y, Li H, Huang C, Meng XM, Zhang L, Lv XW, Li J. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway. Mol Immunol 2020;126:31-9. [PMID: 32745796 DOI: 10.1016/j.molimm.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wang F, Malnassy G, Qiu W. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Front Oncol 2021;11:653037. [PMID: 33791228 DOI: 10.3389/fonc.2021.653037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Yan J, Feng Y, Fang X, Cui X, Xia X, Li F, Luo W, Liang J, Feng J, Yu K. Anti-liver fibrosis effects of the total flavonoids of litchi semen on CCl4-induced liver fibrosis in rats associated with the upregulation of retinol metabolism. Pharm Biol 2022;60:1264-77. [PMID: 35787093 DOI: 10.1080/13880209.2022.2086584] [Reference Citation Analysis]
11 Wiśniewska J, Sadowska A, Wójtowicz A, Słyszewska M, Szóstek-Mioduchowska A. Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies. Life (Basel) 2021;11:1068. [PMID: 34685439 DOI: 10.3390/life11101068] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu JJ, Zhu L, Li HD, Du XS, Li JJ, Yin NN, Meng XM, Huang C, Li J. DNMT3a-mediated methylation of PSTPIP2 enhances inflammation in alcohol-induced liver injury via regulating STAT1 and NF-κB pathway. Pharmacol Res 2022;:106125. [PMID: 35149186 DOI: 10.1016/j.phrs.2022.106125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen X, Li HD, Bu FT, Li XF, Chen Y, Zhu S, Wang JN, Chen SY, Sun YY, Pan XY, Yin NN, Xu JJ, Huang C, Li J. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics 2020;10:4851-70. [PMID: 32308754 DOI: 10.7150/thno.42423] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
14 Shan L, Liu Z, Ci L, Shuai C, Lv X, Li J. Research progress on the anti-hepatic fibrosis action and mechanism of natural products. Int Immunopharmacol 2019;75:105765. [PMID: 31336335 DOI: 10.1016/j.intimp.2019.105765] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
15 Zhang J, Liu Q, He J, Li Y. Novel Therapeutic Targets in Liver Fibrosis. Front Mol Biosci 2021;8:766855. [PMID: 34805276 DOI: 10.3389/fmolb.2021.766855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Xue J, Xiao T, Wei S, Sun J, Zou Z, Shi M, Sun Q, Dai X, Wu L, Li J, Xia H, Tang H, Zhang A, Liu Q. miR-21-regulated M2 polarization of macrophage is involved in arsenicosis-induced hepatic fibrosis through the activation of hepatic stellate cells. J Cell Physiol 2021;236:6025-41. [PMID: 33481270 DOI: 10.1002/jcp.30288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liao Y, Zhao T, Li LY, Wang FQ. Elevated Sad1 and UNC84 Domain Containing 2 (SUN2) level inhibits cell growth and aerobic glycolysis in oral cancer through reducing the expressions of glucose transporter 1 (GLUT1) and lactate dehydrogenase A (LDHA). J Dent Sci 2021;16:460-6. [PMID: 33384835 DOI: 10.1016/j.jds.2020.08.007] [Reference Citation Analysis]
18 Yang L, Liu Y, Sun Y, Huang C, Li J, Wang Y. New advances of DNA/RNA methylation modification in liver fibrosis. Cell Signal 2021;:110224. [PMID: 34954394 DOI: 10.1016/j.cellsig.2021.110224] [Reference Citation Analysis]
19 Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of Alcohol-Related Liver Diseases. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ibrahim SA, Mohamed MZ, El-Tahawy NF, Abdelrahman AM. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Can J Physiol Pharmacol 2021;99:313-20. [PMID: 32721217 DOI: 10.1139/cjpp-2020-0159] [Reference Citation Analysis]
21 Du Z, Liu M, Wang Z, Lin Z, Feng Y, Tian D, Xia L. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. Cell Prolif 2021;54:e13072. [PMID: 34031939 DOI: 10.1111/cpr.13072] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Essawy N, Samson C, Petitalot A, Moog S, Bigot A, Herrada I, Marcelot A, Arteni AA, Coirault C, Zinn-Justin S. An Emerin LEM-Domain Mutation Impairs Cell Response to Mechanical Stress. Cells 2019;8:E570. [PMID: 31185657 DOI: 10.3390/cells8060570] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Chen X, Li XF, Chen Y, Zhu S, Li HD, Chen SY, Wang JN, Pan XY, Bu FT, Huang C, Li J. Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. Int Immunopharmacol 2019;76:105838. [PMID: 31473406 DOI: 10.1016/j.intimp.2019.105838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Chen L, Huang W, Wang L, Zhang Z, Zhang F, Zheng S, Kong D. The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism. Expert Rev Gastroenterol Hepatol 2020;14:259-70. [PMID: 32124651 DOI: 10.1080/17474124.2020.1736042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Mota EA, Patrocínio ABD, Rodrigues V, da Silva JS, Pereira VC, Guerra-Sá R. Epigenetic and parasitological parameters are modulated in EBi3-/- mice infected with Schistosoma mansoni. PLoS Negl Trop Dis 2020;14:e0008080. [PMID: 32078636 DOI: 10.1371/journal.pntd.0008080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Li H, Chen X, Xu J, Du X, Yang Y, Li J, Yang X, Huang H, Li X, Wu M, Zhang C, Zhang C, Li Z, Wang H, Meng X, Huang C, Li J. DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathway. Clinical Science 2020;134:1935-56. [DOI: 10.1042/cs20200031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Lin HY, Yang YL, Wang PW, Wang FS, Huang YH. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Cells 2020;9:E1041. [PMID: 32331364 DOI: 10.3390/cells9041041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
28 Xue T, Qiu X, Liu H, Gan C, Tan Z, Xie Y, Wang Y, Ye T. Epigenetic regulation in fibrosis progress. Pharmacol Res 2021;173:105910. [PMID: 34562602 DOI: 10.1016/j.phrs.2021.105910] [Reference Citation Analysis]